The impact of dietary, surgical, and pharmacological interventions on gut microbiota in individuals with diabetes mellitus: A systematic review

Diabetes Res Clin Pract. 2022 Jul:189:109944. doi: 10.1016/j.diabres.2022.109944. Epub 2022 Jun 10.

Abstract

Aims: To conduct a systematic review assessing the association between dietary, surgical, and pharmacological interventions and changes in the gut microbiota of individuals with diabetes.

Methods: The MEDLINE, EMBASE, and Cochrane Library databases were searched focusing on the effects of dietary, bariatric surgery, and pharmacological interventions on gut microbiota in adults with diabetes. Studies were classified based on qualitative changes using a simple vote-counting method, evaluating reduction, no effect, or an increase in the gut microbiota outcomes.

Results: 6,004 studies were retained to review their titles and abstracts. A total of 149 full-text articles were reassessed, of which 49 were included in the final analysis. This review indicates that dietary, surgical, and pharmacological interventions increase or decrease bacterial populations from more than 60 families, genera, or species. In general, the interventions led to an increase in the bacterial population from phylum Firmicutes, mainly Lactobacillus species, compared to the gram-negative bacterial population from phylum Bacteroidetes.

Conclusions: The results of the included studies suggest that interventions aimed at reducing species related to uncontrolled diabetes and increasing species related to the healthy gut are potential adjuvants in treating diabetes; however, well-conducted interventional studies targeting gut microbiota are necessary.

Keywords: Diabetes mellitus; Lactobacillus; Microbiota.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Adult
  • Bacteria
  • Bariatric Surgery*
  • Diabetes Mellitus*
  • Diet
  • Gastrointestinal Microbiome*
  • Humans